On March, 27 is expected Walgreens Boots Alliance, Inc. (NASDAQ:WBA)’s earnings report, Zacks reports. Analysts forecast $1.74 earnings per share. That’s $0.01 up or 0.58 % from 2018’s earnings of $1.73. If $1.74 is reported, WBA’s profit will be $1.64B for 9.00 P/E. After $1.46 earnings per share was announced previous quarter, analysts now see EPS growth of 19.18 % for Walgreens Boots Alliance, Inc.. Ticker’s shares touched $62.67 during the last trading session after 0.06% change.Walgreens Boots Alliance, Inc. has volume of 556,581 shares. Since March 18, 2018 WBA has declined 7.78% and is downtrending. WBA underperformed the S&P 500 by 12.15%.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Coverage
In total 8 analysts cover Walgreens Boots Alliance (NASDAQ:WBA). “Buy” rating has 2, “Sell” are 2, while 4 are “Hold”. 25% are bullish. With $91 highest and $65 lowest PT Walgreens Boots Alliance has $75.43 average PT or 20.36% above the current ($62.67) price. 14 are the (NASDAQ:WBA)’s analyst reports since October 8, 2018 according to StockzIntelligence Inc. On Monday, October 8 JP Morgan maintained Walgreens Boots Alliance, Inc. (NASDAQ:WBA) with “Overweight” rating. On Friday, October 12 the firm has “Neutral” rating by Robert W. Baird given. On Monday, October 8 the stock has “Outperform” rating by RBC Capital Markets. In Tuesday, March 5 report Morgan Stanley maintained the stock with “Equal-Weight” rating. In Monday, March 4 report UBS maintained it with “Sell” rating and $65 target. On Friday, December 21 the company was maintained by Robert W. Baird. On Friday, March 1 the rating was maintained by Robert W. Baird with “Neutral”. On Monday, December 3 the firm earned “Equal-Weight” rating by Morgan Stanley. On Friday, December 14 the stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) earned “Sell” rating by Goldman Sachs. The company rating was maintained by Citigroup on Friday, October 12.
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company.The company has $59.13 billion market cap. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale.11.53 is the P/E ratio. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
For more Walgreens Boots Alliance, Inc. (NASDAQ:WBA) news published briefly go to: Nasdaq.com, Nasdaq.com, Seekingalpha.com, Nasdaq.com or Bizjournals.com. The titles are as follows: “What to Expect from FedEx’s (FDX) Q3 Earnings – Nasdaq” published on March 15, 2019, “Here’s Why You Should Invest in Walgreens Boots Stock Now – Nasdaq” on September 25, 2018, “What Walgreens Cannot Get Right – Seeking Alpha” with a publish date: December 21, 2018, “Walgreens (WBA) Tops Q3 Earnings Estimates, Narrows View – Nasdaq” and the last “FDA chairman chides Walgreens for ‘disturbing’ illegal tobacco sales to minors – Chicago Business Journal” with publication date: March 05, 2019.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.